Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medifast (MED) Current Deferred Revenue (2018 - 2020)

Historic Current Deferred Revenue for Medifast (MED) over the last 3 years, with Q4 2020 value amounting to $7.6 million.

  • Medifast's Current Deferred Revenue rose 7553.66% to $7.6 million in Q4 2020 from the same period last year, while for Dec 2020 it was $7.6 million, marking a year-over-year increase of 7553.66%. This contributed to the annual value of $7.6 million for FY2020, which is 7553.66% up from last year.
  • Medifast's Current Deferred Revenue amounted to $7.6 million in Q4 2020, which was up 7553.66% from $4.3 million recorded in Q4 2019.
  • Medifast's 5-year Current Deferred Revenue high stood at $7.6 million for Q4 2020, and its period low was $2.8 million during Q4 2018.
  • Its 3-year average for Current Deferred Revenue is $4.9 million, with a median of $4.3 million in 2019.
  • In the last 5 years, Medifast's Current Deferred Revenue skyrocketed by 5491.6% in 2019 and then soared by 7553.66% in 2020.
  • Medifast's Current Deferred Revenue (Quarter) stood at $2.8 million in 2018, then surged by 54.92% to $4.3 million in 2019, then skyrocketed by 75.54% to $7.6 million in 2020.
  • Its Current Deferred Revenue was $7.6 million in Q4 2020, compared to $4.3 million in Q4 2019 and $2.8 million in Q4 2018.